Literature DB >> 23225107

Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.

Hung-Hsu Hung1, Hao-Jan Lei, Gar-Yang Chau, Chien-Wei Su, Cheng-Yuan Hsia, Wei-Yu Kao, Wing-Yiu Lui, Wen-Chieh Wu, Han-Chieh Lin, Jaw-Ching Wu.   

Abstract

AIMS: This study aims to evaluate the risk factors for tumor recurrence beyond the Milan criteria (MC) for patients with hepatocellular carcinoma (HCC) after surgical resection (SR) in which salvage liver transplantation is relatively contraindicated.
METHODS: A total of 447 patients who underwent SR for HCC were enrolled consecutively. Among them, 248 and 199 patients were within the Milan criteria and beyond the Milan criteria (BMC group), respectively. Overall survival, recurrence, and disease-free survival were analyzed by multivariate analysis.
RESULTS: After a median follow-up of 34.4 months, 130 patients died. Microvascular invasion, higher Edmondson stage of tumor cell differentiation, BMC group, and no anti-viral therapy were associated with poor overall survival. Multi-nodularity, higher Edmondson stage, BMC group, and no anti-viral therapy were independent risk factors for tumor recurrence, while BMC group and no anti-viral therapy were independent risk factors for disease-free survival. The Milan criteria, multi-nodularity, and microvascular invasion were used to stratify the patients into low-, medium-, and high-risk groups for tumor recurrence outside the MC and showed statistical significance (low vs. medium, p = 0.011; low vs. high, p < 0.001; medium vs. high, p = 0.009).
CONCLUSIONS: The combination of the MC, multi-nodularity, and microvascular invasion predict the post-operative recurrence of HCC and may provide a roadmap for further treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23225107     DOI: 10.1007/s11605-012-2087-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

Authors:  Wei-Yu Kao; Yi-You Chiou; Hung-Hsu Hung; Chien-Wei Su; Yi-Hong Chou; Teh-Ia Huo; Yi-Hsiang Huang; Wen-Chieh Wu; Han-Chieh Lin; Shou-Dong Lee; Jaw-Ching Wu
Journal:  J Clin Gastroenterol       Date:  2012-01       Impact factor: 3.062

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

Authors:  Margarita Sala; Josep Fuster; Josep M Llovet; Miquel Navasa; Manel Solé; María Varela; Fernando Pons; Antoni Rimola; Juan Carlos García-Valdecasas; Concepció Brú; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

Review 4.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

Review 5.  General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?

Authors:  Masato Fujiki; Federico Aucejo; Richard Kim
Journal:  Liver Int       Date:  2011-09       Impact factor: 5.828

6.  Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation.

Authors:  Alessandro Cucchetti; Matteo Cescon; Giorgio Ercolani; Maria Cristina Morelli; Massimo Del Gaudio; Matteo Zanello; Antonio Daniele Pinna
Journal:  Transpl Int       Date:  2011-05-26       Impact factor: 3.782

7.  A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.

Authors:  Wei-Yu Kao; Chien-Wei Su; Gar-Yang Chau; Wing-Yiu Lui; Chew-Wun Wu; Jaw-Ching Wu
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

8.  Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.

Authors:  S T Fan; R T P Poon; C Yeung; C M Lam; C M Lo; W K Yuen; K K C Ng; C L Liu; S C Chan
Journal:  Br J Surg       Date:  2011-06-07       Impact factor: 6.939

9.  Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Authors:  Francis Y Yao; Robert K Kerlan; Ryutaro Hirose; Timothy J Davern; Nathan M Bass; Sandy Feng; Marion Peters; Norah Terrault; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  11 in total

Review 1.  Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Authors:  Gar-Yang Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Predicting recurrence patterns after resection of hepatocellular cancer.

Authors:  Ser Yee Lee; Ioannis T Konstantinidis; Anne A Eaton; Mithat Gönen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

3.  Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.

Authors:  Chuan Li; Wen-Jiang Zhu; Tian-Fu Wen; Yan Dai; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Ming-Qing Xu
Journal:  J Gastrointest Surg       Date:  2014-06-06       Impact factor: 3.452

4.  Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging.

Authors:  Changxian Li; Hongwei Wang; Ruixiang Chen; Hui Zhang; Yonghua Xu; Bin Zhang; Yong Li; Changhe Zhang; Yue Yang; Xuehao Wang; Xiangcheng Li
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

5.  High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.

Authors:  Peipei Song; Yoshinori Inagaki; Zhigang Wang; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Junichi Arita; Wei Tang; Norihiro Kokudo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Oncotarget       Date:  2016-12-06

7.  The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.

Authors:  Junyi Shen; Jun Wen; Chuan Li; Tianfu Wen; Lvnan Yan; Bo Li; Jiayin Yang; Changli Lu
Journal:  BMC Cancer       Date:  2018-03-12       Impact factor: 4.430

8.  The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade.

Authors:  Kuan-Chieh Fang; Wei-Yu Kao; Chien-Wei Su; Po-Chun Chen; Pei-Chang Lee; Yi-Hsiang Huang; Teh-Ia Huo; Chun-Chao Chang; Ming-Chih Hou; Han-Chieh Lin; Jaw-Ching Wu
Journal:  Liver Cancer       Date:  2018-03-14       Impact factor: 11.740

9.  Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.

Authors:  Wei-Yu Kao; Yee Chao; Chun-Chao Chang; Chung-Pin Li; Chien-Wei Su; Teh-Ia Huo; Yi-Hsiang Huang; Yu-Jia Chang; Han-Chieh Lin; Jaw-Ching Wu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection.

Authors:  Jiliang Feng; Junmei Chen; Ruidong Zhu; Lu Yu; Yan Zhang; Dezhao Feng; Heli Kong; Chenzhao Song; Hui Xia; Jushan Wu; Dawei Zhao
Journal:  Oncotarget       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.